Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379(9811):165–180. https://doi.org/10.1016/S0140-6736(11)60178-5

Article  PubMed  Google Scholar 

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260–272. https://doi.org/10.1016/S0140-6736(13)60687-X

Article  PubMed  Google Scholar 

Finkel T (2011) Signal transduction by reactive oxygen species. J Cell Biol 194(1):7–15. https://doi.org/10.1083/jcb.201102095

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anders HJ (2014) Immune system modulation of kidney regeneration—Mechanisms and implications. Nat Rev Nephrol 10(6):347–358. https://doi.org/10.1038/nrneph.2014.70

Article  CAS  PubMed  Google Scholar 

Pethő ÁG, Tapolyai M, Csongrádi É, Orosz P (2024) Management of chronic kidney disease: the current novel and forgotten therapies. J Clin Transl Endocrinol 36:100354. https://doi.org/10.1016/j.jcte.2024.100354

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin C, Wang N (2016) Kidney injury molecule-1 in kidney disease. Ren Fail 38(10):1567–1573. https://doi.org/10.1080/0886022X.2016.1193816

Article  CAS  PubMed  Google Scholar 

Song J, Yu J, Prayogo GW, Cao W, Wu Y, Jia Z, Zhang A (2019) Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology. Am J Trans Res 11(3):1219–1229

CAS  Google Scholar 

Devarajan P (2008) Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scandinavian J Clin Lab Investig 241:89–94. https://doi.org/10.1080/00365510802150158

Article  CAS  Google Scholar 

Megallaa MHZ, Abdel Salam MS, Saad NLM, Ahmed Altair MNAH, Amin NG (2023) NGAL (Neutrophil Gelatinase-Associated Lipocalin) as an early biomarker of nephropathy in patients with type 2 diabetes. Alexandria J Med 59(1):52–58. https://doi.org/10.1080/20905068.2023.2230051

Article  CAS  Google Scholar 

Shamsi A, Anwar S, Mohammad T, Shahwan M, Hassan MI, Islam A (2022) Therapeutic potential of polyphenols in Alzheimer’s therapy: Broad-spectrum and minimal side effects as key aspects. Autism spectrum disorder and Alzheimer’s disease: advances in research. Springer, Berlin, pp 111–133

Google Scholar 

Majrashi TA, Alshehri SA, Alsayari A, Muhsinah AB, Alrouji M, Alshahrani AM, Shamsi A, Atiya A (2023) Insight into the biological roles and mechanisms of phytochemicals in different types of cancer: targeting cancer therapeutics. Nutrients 15(7):1704. https://doi.org/10.3390/nu15071704

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas AH, Jaremko M (2020) Important flavonoids and their role as a therapeutic agent. Molecules (Basel, Switzerland) 25(22):5243. https://doi.org/10.3390/molecules25225243

Article  CAS  PubMed  Google Scholar 

Shamsi A, Ahmed A, Bano B (2016) Glyoxal induced structural transition of buffalo kidney cystatin to molten globule and aggregates: anti-fibrillation potency of quinic acid. IUBMB Life 68(2):156–166. https://doi.org/10.1002/iub.1471

Article  CAS  PubMed  Google Scholar 

Hadidi M, Liñán-Atero R, Tarahi M, Christodoulou MC, Aghababaei F (2024) The potential health benefits of gallic acid: therapeutic and food applications. Antioxidants (Basel, Switzerland) 13(8):1001. https://doi.org/10.3390/antiox13081001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang DJ, Moh SH, Son DH, You S, Kinyua AW, Ko CM, Song M, Yeo J, Choi YH, Kim KW (2016) Gallic acid promotes wound healing in normal and hyperglucidic conditions. Molecules 21:899

Article  PubMed  PubMed Central  Google Scholar 

Lemos MRB, Zambiazi R (2013) Gallic acid: occurrences, antioxidant activity and health implications. In: Thompson MA, Collins RP (eds) Handbook on gallic acid: natural occurrences, antioxidant properties and health implications. Hauppauge, Nova, pp 193–213

Google Scholar 

Kahkeshani N, Farzaei F, Fotouhi M, Alavi SS, Bahramsoltani R, Naseri R, Momtaz S, Abbasabadi Z, Rahimi R, Farzaei MH, Bishayee A (2019) Pharmacological effects of gallic acid in health and diseases: a mechanistic review. Iranian J Basic Med Sci 22(3):225–237. https://doi.org/10.22038/ijbms.2019.32806.7897

Article  Google Scholar 

Giftson J, Jayanthi S, Nalini N (2010) Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1, 2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 28:251–259

Article  CAS  PubMed  Google Scholar 

Govea-Salas M, Rivas-Estilla AM, Rodríguez-Herrera R, Lozano-Sepúlveda SA, Aguilar-Gonzalez CN, Zugasti-Cruz A, Salas-Villalobos TB, Morlett-Chávez JA (2016) Gallic acid decreases hepatitis C virus expression through its antioxidant capacity. Exp Ther Med 11(2):619–624. https://doi.org/10.3892/etm.2015.2923

Article  CAS  PubMed  Google Scholar 

Vijaya Padma V, Sowmya P, Arun Felix T, Baskaran R, Poornima P (2011) Protective effect of gallic acid against lindane induced toxicity in experimental rats. Food Chem Toxicol 49(4):991–998. https://doi.org/10.1016/j.fct.2011.01.005

Article  CAS  PubMed  Google Scholar 

Asci H, Ozmen O, Ellidag HY, Aydin B, Bas E, Yilmaz N (2017) The impact of gallic acid on the methotrexate-induced kidney damage in rats. J Food Drug Anal 25(4):890–897. https://doi.org/10.1016/j.jfda.2017.05.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang K, Zhang L, Liao P, Xiao Z, Zhang F, Sindaye D, Xin Z, Tan C, Deng J, Yin Y, Deng B (2020) Impact of Gallic Acid on Gut Health: Focus on the Gut Microbiome, Immune Response, and Mechanisms of Action. Front Immunol 11:580208. https://doi.org/10.3389/fimmu.2020.580208

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmadvand H, Yalameha B, Adibhesami G, Nasri M, Naderi N, Babaeenezhad E, Nouryazdan N (2019) The protective role of gallic acid pretreatment on renal ischemia-reperfusion injury in rats. Rep Biochem Mol Biol 8(1):42–48

CAS  PubMed  PubMed Central  Google Scholar 

Hong Y, Wang J, Sun W, Zhang L, Xu X, Zhang K (2023) Gallic acid improves the metformin effects on diabetic kidney disease in mice. Ren Fail 45(1):2183726. https://doi.org/10.1080/0886022X.2023.2183726

Article  PubMed  PubMed Central  Google Scholar 

Peng CC, Hsieh CL, Wang HE, Chung JY, Chen KC, Peng RY (2012) Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease. Clin Nutr (Edinburgh, Scotland) 31(3):405–414. https://doi.org/10.1016/j.clnu.2011.11.003

Article  CAS  Google Scholar 

Alhazmi AI, El-Refaei MF, Abdallah EAA (2024) Protective effects of gallic acid against nickel-induced kidney injury: impact of antioxidants and transcription factor on the incidence of nephrotoxicity. Ren Fail 46(1):2344656. https://doi.org/10.1080/0886022X.2024.2344656

Article  PubMed  PubMed Central  Google Scholar 

Kotb E, Serag W, Elshaarawy R, Hafez H, Elkhayat Z (2021) The protective role of gallic acid in cisplatin nephrotoxicity. Front Sci Res Technol 2(1):48–52. https://doi.org/10.21608/fsrt.2021.77860.1040

Article  Google Scholar 

Baharmi S, Kalantari H, Kalantar M, Goudarzi M, Mansouri E, Kalantar H (2022) Pretreatment with gallic acid mitigates cyclophosphamide induced inflammation and oxidative stress in mice. Curr Mol Pharmacol 15(1):204–212. https://doi.org/10.2174/1874467214666210531162741

Article  CAS  PubMed  Google Scholar 

Yokozawa T, Zheng PD, Oura H, Koizumi F (1986) Animal model of adenine-induced chronic renal failure in rats. Nephron 44(3):230–234. https://doi.org/10.1159/000183992

Article  CAS  PubMed  Google Scholar 

Waly H, Ezz El-Arab RF, Abou Khalil NS, Hassanein KMA, Bassam A-S, Saleh SMM (2024) Gallic acid counteracts tartrazine-induced testicular dysfunction in rats: biochemical, histopathological and ultrastructural evidences. JoBAZ. https://doi.org/10.1186/s41936-024-00370-0